tradingkey.logo
tradingkey.logo
Pesquisar

Enovis Corp

ENOV
Adicionar à lista de desejos
21.700USD
+1.660+8.28%
Fechamento 07/02, 13:00ETCotações atrasadas em 15 min
1.25BValor de mercado
PerdaP/L TTM

Mais detalhes de Enovis Corp Empresa

Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing high-quality medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative diseases. The Prevention & Recovery products are marketed under several brand names, such as DJO. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. It also operates a Enovis Growth eXcellence business system (EGX).

Informações de Enovis Corp

Código da empresaENOV
Nome da EmpresaEnovis Corp
Data de listagemMay 08, 2008
CEOMcdonald (Damien)
Número de funcionários7367
Tipo de títulosOrdinary Share
Fim do ano fiscalMay 08
Endereço2711 Centerville Road
CidadeWILMINGTON
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal19808
Telefone13022529160
Sitehttps://www.enovis.com/
Código da empresaENOV
Data de listagemMay 08, 2008
CEOMcdonald (Damien)

Executivos da empresa Enovis Corp

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Daniel Alexis Pryor
Mr. Daniel Alexis Pryor
Executive Vice President - Strategy and Business Development
Executive Vice President - Strategy and Business Development
127.55K
+10.74%
Ms. Sharon L. Wienbar
Ms. Sharon L. Wienbar
Independent Chairman of the Board
Independent Chairman of the Board
41.95K
+22.28%
Mr. Rajiv Vinnakota
Mr. Rajiv Vinnakota
Independent Director
Independent Director
27.46K
+34.03%
Mr. Liam J. Kelly
Mr. Liam J. Kelly
Independent Director
Independent Director
22.35K
+41.81%
Dr. Christine Ortiz, Ph.D.
Dr. Christine Ortiz, Ph.D.
Independent Director
Independent Director
18.37K
+50.87%
Mr. Terry D. Ross
Mr. Terry D. Ross
Group President - Prevention and Recovery
Group President - Prevention and Recovery
18.10K
-95.45%
Ms. Barbara W. Bodem
Ms. Barbara W. Bodem
Independent Director
Independent Director
17.60K
+53.09%
Mr. A. Clayton Perfall
Mr. A. Clayton Perfall
Independent Director
Independent Director
--
--
Mr. Brady R. Shirley
Mr. Brady R. Shirley
Director
Director
--
--
Mr. Bradley J. (Brad) Tandy, J.D.
Mr. Bradley J. (Brad) Tandy, J.D.
Senior Vice President, Chief Legal Officer
Senior Vice President, Chief Legal Officer
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Daniel Alexis Pryor
Mr. Daniel Alexis Pryor
Executive Vice President - Strategy and Business Development
Executive Vice President - Strategy and Business Development
127.55K
+10.74%
Ms. Sharon L. Wienbar
Ms. Sharon L. Wienbar
Independent Chairman of the Board
Independent Chairman of the Board
41.95K
+22.28%
Mr. Rajiv Vinnakota
Mr. Rajiv Vinnakota
Independent Director
Independent Director
27.46K
+34.03%
Mr. Liam J. Kelly
Mr. Liam J. Kelly
Independent Director
Independent Director
22.35K
+41.81%
Dr. Christine Ortiz, Ph.D.
Dr. Christine Ortiz, Ph.D.
Independent Director
Independent Director
18.37K
+50.87%
Mr. Terry D. Ross
Mr. Terry D. Ross
Group President - Prevention and Recovery
Group President - Prevention and Recovery
18.10K
-95.45%

Perguntas frequentes

Quem são os cinco principais acionistas de Enovis Corp?

Os cinco principais acionistas de Enovis Corp são: Mr. Daniel Alexis Pryor

Quantas instituições possuem ações da Enovis Corp (ENOV)?

Em 2026Q1, 652 instituições possuíam ações da Enovis Corp, com valor de mercado aproximado de 68.97M, representando 119.81% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em -6763998.00.

Qual é a maior fonte de receita da Enovis Corp?

Em 2026Q1, o segmento de negócios Medical Technology-Prevention & Rehabilitation gerou a maior receita para Enovis Corp, totalizando 1.14B e representando 50.58% da receita total.